Consumer Food Decisions and GLP-1-Based Medications
Virtual, Event
May 7, 2024
3:00 pm – 4:00 pm
Speaker: Dr. Brandon McFadden, University of Arkansas
Title: Consumer Food Decisions and GLP-1-Based Medications
Glucagon-like peptide-1 (GLP-1) agonists were originally developed to control glucose levels in people with Type 2 diabetes, but have more recently become popular as weight-loss medications. What is the impact of GLP-1 medications on food and beverage purchasing habits? Are there reductions in the size of shopping baskets when there are household members on a GLP-1 medication? Or, are GLP-1 households making shifts in their food and beverage choices? Is this a opportunity for food and beverage companies to continue innovating with healthier recipes, premium ingredients, and packaging that align with consumer needs and preferences?
The webinar was followed by an invitation-only dialogue with Dr. McFadden.
For more information, please contact science@iafns.org